Cargando…

A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases

BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Yangyue, Xiong, Ruiyan, Zhu, Yuxiao, Luan, Ning, Yu, Chuanxin, Yang, Kun, Wang, Huiquan, Xu, Xuejun, Yang, Yuxuan, Sun, Siyu, Shi, Liyun, Padde, Jon Rob, Chen, Lin, Chen, Lu, Hou, Min, Xu, Zhipeng, Lai, Ren, Ji, Minjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448429/
https://www.ncbi.nlm.nih.gov/pubmed/37579625
http://dx.doi.org/10.1016/j.ebiom.2023.104751
_version_ 1785094731575853056
author Ni, Yangyue
Xiong, Ruiyan
Zhu, Yuxiao
Luan, Ning
Yu, Chuanxin
Yang, Kun
Wang, Huiquan
Xu, Xuejun
Yang, Yuxuan
Sun, Siyu
Shi, Liyun
Padde, Jon Rob
Chen, Lin
Chen, Lu
Hou, Min
Xu, Zhipeng
Lai, Ren
Ji, Minjun
author_facet Ni, Yangyue
Xiong, Ruiyan
Zhu, Yuxiao
Luan, Ning
Yu, Chuanxin
Yang, Kun
Wang, Huiquan
Xu, Xuejun
Yang, Yuxuan
Sun, Siyu
Shi, Liyun
Padde, Jon Rob
Chen, Lin
Chen, Lu
Hou, Min
Xu, Zhipeng
Lai, Ren
Ji, Minjun
author_sort Ni, Yangyue
collection PubMed
description BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Thus, constructing a “Tregs-induction”-based discovery pipeline from parasitic helminth is a promising strategy to control autoimmune and inflammatory diseases. METHODS: The gel filtration chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC) were used to isolate immunomodulatory components from the egg extracts of Schistosoma japonicum. The extracted peptides were evaluated for their effects on Tregs suppressive functions using flow cytometry, ELISA and T cell suppression assay. Finally, we carried out colitis and psoriasis models to evaluate the function of Tregs induced by helminth-derived peptide in vivo. FINDINGS: Here, based on target-driven discovery strategy, we successfully identified a small 3 kDa peptide (SjDX5-53) from egg extracts of schistosome, which promoted both human and murine Tregs production. SjDX5-53 presented immunosuppressive function by arresting dendritic cells (DCs) at an immature state and augmenting the proportion and suppressive capacity of Tregs. In mouse models, SjDX5-53 protected mice against autoimmune-related colitis and psoriasis through inducing Tregs and inhibiting inflammatory T-helper (Th) 1 and Th17 responses. INTERPRETATION: SjDX5-53 exhibited the promising therapeutic effects in alleviating the phenotype of immune-related colitis and psoriasis. This study displayed a screening and validation pipeline of the inducer of Tregs from helminth eggs, highlighting the discovery of new biologics inspired by co-evolution of hosts and their parasites. FUNDING: This study was supported by the 10.13039/501100001809Natural Science Foundation of China (82272368) and 10.13039/501100004608Natural Science Foundation of Jiangsu Province (BK20211586).
format Online
Article
Text
id pubmed-10448429
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104484292023-08-25 A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases Ni, Yangyue Xiong, Ruiyan Zhu, Yuxiao Luan, Ning Yu, Chuanxin Yang, Kun Wang, Huiquan Xu, Xuejun Yang, Yuxuan Sun, Siyu Shi, Liyun Padde, Jon Rob Chen, Lin Chen, Lu Hou, Min Xu, Zhipeng Lai, Ren Ji, Minjun eBioMedicine Articles BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Thus, constructing a “Tregs-induction”-based discovery pipeline from parasitic helminth is a promising strategy to control autoimmune and inflammatory diseases. METHODS: The gel filtration chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC) were used to isolate immunomodulatory components from the egg extracts of Schistosoma japonicum. The extracted peptides were evaluated for their effects on Tregs suppressive functions using flow cytometry, ELISA and T cell suppression assay. Finally, we carried out colitis and psoriasis models to evaluate the function of Tregs induced by helminth-derived peptide in vivo. FINDINGS: Here, based on target-driven discovery strategy, we successfully identified a small 3 kDa peptide (SjDX5-53) from egg extracts of schistosome, which promoted both human and murine Tregs production. SjDX5-53 presented immunosuppressive function by arresting dendritic cells (DCs) at an immature state and augmenting the proportion and suppressive capacity of Tregs. In mouse models, SjDX5-53 protected mice against autoimmune-related colitis and psoriasis through inducing Tregs and inhibiting inflammatory T-helper (Th) 1 and Th17 responses. INTERPRETATION: SjDX5-53 exhibited the promising therapeutic effects in alleviating the phenotype of immune-related colitis and psoriasis. This study displayed a screening and validation pipeline of the inducer of Tregs from helminth eggs, highlighting the discovery of new biologics inspired by co-evolution of hosts and their parasites. FUNDING: This study was supported by the 10.13039/501100001809Natural Science Foundation of China (82272368) and 10.13039/501100004608Natural Science Foundation of Jiangsu Province (BK20211586). Elsevier 2023-08-12 /pmc/articles/PMC10448429/ /pubmed/37579625 http://dx.doi.org/10.1016/j.ebiom.2023.104751 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Ni, Yangyue
Xiong, Ruiyan
Zhu, Yuxiao
Luan, Ning
Yu, Chuanxin
Yang, Kun
Wang, Huiquan
Xu, Xuejun
Yang, Yuxuan
Sun, Siyu
Shi, Liyun
Padde, Jon Rob
Chen, Lin
Chen, Lu
Hou, Min
Xu, Zhipeng
Lai, Ren
Ji, Minjun
A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title_full A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title_fullStr A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title_full_unstemmed A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title_short A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
title_sort target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448429/
https://www.ncbi.nlm.nih.gov/pubmed/37579625
http://dx.doi.org/10.1016/j.ebiom.2023.104751
work_keys_str_mv AT niyangyue atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xiongruiyan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT zhuyuxiao atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT luanning atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yuchuanxin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yangkun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT wanghuiquan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xuxuejun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yangyuxuan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT sunsiyu atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT shiliyun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT paddejonrob atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT chenlin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT chenlu atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT houmin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xuzhipeng atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT lairen atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT jiminjun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT niyangyue targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xiongruiyan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT zhuyuxiao targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT luanning targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yuchuanxin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yangkun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT wanghuiquan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xuxuejun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT yangyuxuan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT sunsiyu targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT shiliyun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT paddejonrob targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT chenlin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT chenlu targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT houmin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT xuzhipeng targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT lairen targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases
AT jiminjun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases